Ramtin Agah - 15 Mar 2023 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director
Signature
/s/ Shaun Bagai, by power of attorney
Issuer symbol
RNXT
Transactions as of
15 Mar 2023
Net transactions value
$0
Form type
4
Filing time
29 Mar 2023, 16:57:57 UTC
Previous filing
09 Jun 2022
Next filing
23 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNXT Employee Stock Option (right to buy) Award $0 +65,000 $0.000000 65,000 15 Mar 2023 Common Stock 65,000 $3.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in 48 equal monthly installments beginning on January 1, 2023.